Sufentanil Citrate (bulk) Coupons & Savings Card – Discount Prices from $14409.00

Sufentanil citrate is a potent opioid analgesic used in medical settings for pain management and anesthesia. While effective, it carries significant risks that require careful consideration.

Addiction, Abuse, and Misuse: Sufentanil citrate has a high potential for addiction, abuse, and misuse, which can lead to overdose and death. Healthcare providers should assess each patient's risk before prescribing and monitor regularly for these behaviors.

Life-Threatening Respiratory Depression: Serious, life-threatening, or fatal respiratory depression may occur with sufentanil citrate use, especially during initiation or following a dosage increase. Proper dosing and titration are essential to minimize this risk.

Risks from Concomitant Use with CNS Depressants: Using sufentanil citrate alongside benzodiazepines or other central nervous system (CNS) depressants, including alcohol, can result in profound sedation, respiratory depression, coma, and death. Such combinations should be reserved for patients with inadequate alternative treatment options.

Cytochrome P450 3A4 Interaction: Concomitant use of sufentanil citrate with CYP3A4 inhibitors may increase sufentanil plasma concentrations, potentially leading to fatal respiratory depression. Conversely, discontinuing a CYP3A4 inducer may also result in increased sufentanil levels. Monitoring patients receiving sufentanil citrate and any CYP3A4 inhibitor or inducer is crucial.

Risks of Muscle Rigidity and Skeletal Muscle Movement: Intravenous administration or unintentional intravascular injection during epidural administration of sufentanil citrate may cause muscle rigidity, particularly involving the muscles of respiration. The incidence and severity of muscle rigidity are dose-related. Management may include the use of neuromuscular blocking agents.

Severe Cardiovascular Depression: Sufentanil citrate may cause severe bradycardia, severe hypotension including orthostatic hypotension, and syncope. Patients with compromised blood pressure maintenance are at increased risk. Monitoring during dosage initiation and titration is essential.

Serotonin Syndrome: Cases of serotonin syndrome, a potentially life-threatening condition, have been reported during concomitant use of sufentanil citrate with serotonergic drugs. Symptoms may include mental status changes, autonomic instability, neuromuscular aberrations, and gastrointestinal symptoms. Discontinue sufentanil citrate if serotonin syndrome is suspected.

Risks Due to Improper Epidural Injection: Proper placement of the needle or catheter in the epidural space should be verified before sufentanil citrate is injected to ensure that unintentional intravascular or intrathecal administration does not occur. Unintentional intravascular injection could result in a potentially serious overdose, including acute truncal muscular rigidity and apnea.

Risks of Use in Patients with Increased Intracranial Pressure, Brain Tumors, or Head Injury: In patients susceptible to the intracranial effects of CO₂ retention, sufentanil citrate may reduce respiratory drive, leading to increased intracranial pressure. Monitoring for sedation and respiratory depression is advised.

Risks of Use in Patients with Gastrointestinal Conditions: Sufentanil citrate may cause spasm of the sphincter of Oddi and increases in serum amylase. Patients with biliary tract disease, including acute pancreatitis, should be monitored for worsening symptoms.

Increased Risk of Seizures in Patients with Seizure Disorders: Sufentanil citrate may increase the frequency of seizures in patients with seizure disorders. Monitoring for worsened seizure control during therapy is recommended.

Risks of Driving and Operating Machinery: Sufentanil citrate may impair the mental or physical abilities needed to perform potentially hazardous activities such as driving a car or operating machinery. Patients should be warned not to drive or operate dangerous machinery unless they are tolerant to the effects of sufentanil citrate and know how they will react to the medication.

Given these risks, sufentanil citrate should be administered only by healthcare professionals trained in the use of potent opioids and the management of their effects.

Sufentanil citrate is a potent opioid analgesic used primarily for pain management during and after surgical procedures. While effective, it carries a range of potential side effects that patients should be aware of. Common Side Effects:

• Respiratory Depression: Sufentanil can slow or shallow breathing, which, if severe, may be life-threatening.
• Cardiovascular Effects: Patients may experience low blood pressure (hypotension) and a slow heart rate (bradycardia), leading to dizziness or fainting.
• Gastrointestinal Issues: Nausea, vomiting, and constipation are frequently reported.
• Neurological Effects: Drowsiness, dizziness, confusion, and muscle stiffness can occur.
• Skin Reactions: Itching and sweating are possible. Serious Side Effects:
• Addiction and Misuse: As an opioid, sufentanil has a risk of addiction, abuse, and misuse, which can lead to overdose and death.
• Serotonin Syndrome: When combined with certain medications that affect serotonin levels, sufentanil may cause serotonin syndrome, characterized by agitation, hallucinations, rapid heartbeat, high blood pressure, fever, nausea, vomiting, diarrhea, muscle rigidity, dizziness, tremor, and seizures.
• Adrenal Insufficiency: Prolonged use may lead to adrenal gland dysfunction, resulting in fatigue, weakness, and low blood pressure.
• Anaphylaxis: Severe allergic reactions, though rare, can occur.
• Androgen Deficiency: Long-term use may lead to hormonal imbalances, affecting sexual function and energy levels.
• Hyperalgesia and Allodynia: Paradoxically, sufentanil may increase sensitivity to pain or cause pain from stimuli that are not normally painful.
• Hypoglycemia: Low blood sugar levels have been reported, especially in patients with risk factors like diabetes. Precautions:
• Concomitant Use with CNS Depressants: Combining sufentanil with other central nervous system depressants, such as benzodiazepines or alcohol, can result in profound sedation, respiratory depression, coma, and death.
• Use in Specific Populations: Elderly, debilitated patients, or those with existing respiratory conditions are at higher risk for severe side effects. Patients should discuss their medical history and current medications with their healthcare provider to minimize risks. Promptly reporting any adverse effects is crucial for safe management.

When taking sufentanil citrate, it's important to be aware of potential interactions with other substances, as these can affect how the medication works and may lead to serious side effects. Here are some key interactions to consider:

Central Nervous System (CNS) Depressants: Combining sufentanil with other CNS depressants, such as benzodiazepines, sedatives, tranquilizers, muscle relaxants, general anesthetics, antipsychotics, other opioids, or alcohol, can result in profound sedation, respiratory depression, coma, and even death. If such combinations are necessary, healthcare providers should prescribe the lowest effective doses and monitor patients closely for signs of respiratory depression and sedation.

Cytochrome P450 3A4 (CYP3A4) Inhibitors and Inducers: Sufentanil is metabolized in the body by the enzyme CYP3A4. Medications that inhibit this enzyme, like certain antibiotics (e.g., Erythromycin), antifungal agents (e.g., Ketoconazole), and protease inhibitors (e.g., Ritonavir), can increase sufentanil levels in the blood, potentially leading to prolonged opioid effects and serious respiratory depression. Conversely, drugs that induce CYP3A4, such as Rifampin, Carbamazepine, and Phenytoin, can decrease sufentanil levels, reducing its effectiveness and possibly causing withdrawal symptoms in dependent individuals. When starting or stopping these medications, healthcare providers should adjust sufentanil dosages accordingly and monitor patients for adverse effects.

Serotonergic Drugs: Using sufentanil alongside medications that affect serotonin levels, including certain antidepressants (e.g., SSRIs, SNRIs, tricyclics), migraine treatments (e.g., triptans), and other serotonergic agents, can increase the risk of serotonin syndrome. This serious condition may present with symptoms like agitation, hallucinations, rapid heartbeat, high blood pressure, fever, muscle rigidity, dizziness, tremor, nausea, vomiting, and diarrhea. If serotonin syndrome is suspected, it's crucial to discontinue sufentanil and seek immediate medical attention.

Monoamine Oxidase Inhibitors (MAOIs): Combining sufentanil with MAOIs, or using sufentanil within 14 days of stopping an MAOI, can lead to severe reactions, including serotonin syndrome or opioid toxicity, characterized by respiratory depression and coma. Therefore, sufentanil should not be used in patients currently taking MAOIs or who have recently discontinued them.

Mixed Agonist/Antagonist and Partial Agonist Opioid Analgesics: Medications like Butorphanol, Nalbuphine, pentazocine, and Buprenorphine may reduce the pain-relieving effects of sufentanil and could precipitate withdrawal symptoms in individuals dependent on opioids. It's advisable to avoid concurrent use of these drugs with sufentanil.

Muscle Relaxants: Sufentanil may enhance the effects of skeletal muscle relaxants, leading to increased respiratory depression. Patients should be monitored for signs of excessive respiratory depression, and dosages of either sufentanil or the muscle relaxant may need to be adjusted.

Diuretics: Opioids like sufentanil can reduce the effectiveness of diuretics by promoting the release of antidiuretic hormone. Patients should be observed for decreased urine output and changes in blood pressure, with adjustments to diuretic dosages made as necessary.

Anticholinergic Drugs: Concurrent use of anticholinergic medications with sufentanil may heighten the risk of urinary retention and severe constipation, potentially leading to a condition called paralytic ileus. Monitoring for these side effects is important when these drugs are used together.

Nitrous Oxide: When used in combination with higher doses of sufentanil, nitrous oxide has been reported to cause cardiovascular depression. Patients should be closely monitored for signs of cardiovascular issues during such combined use.

Always inform your healthcare provider about all medications, supplements, and substances you are currently using to ensure safe and effective treatment with sufentanil citrate.